Rapid HIV Testing Program in the Emergency Department

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-04-30

Study Completion Date

2009-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study is to evaluate the feasibility of a rapid HIV testing program in the Temple University Hospital(TUH)Emergency Department. We hypothesize that a rapid HIV testing program in the TUH Emergency Department is feasible. Patients presenting to the Adult TUH Emergency Department with certain conditions will be offered rapid HIV testing. Testing will be performed by oral swab using the OraQuick Advance test. Patients will receive post-test counseling.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Testing of INSTI™ HIV-1 Antibody Test Kit in Volunteer Subjects at Risk for HIV Infection

NCT00514605

HIV Infections

COMPLETED PHASE2/PHASE3

Impact of a Short-Term Analytical Treatment Interruption and Re-Initiation of Antiretroviral Therapy on Immunologic and Virologic Parameters in HIV-Infected Individuals

NCT03225118

HIV

COMPLETED

Safety and Immune Response to Adjuvanted A(H1N1)v Influenza Vaccine in HIV-1 Infected and Immunosuppressed Adult Patients

NCT01017172

HIV-1 Infection Cancer Immunosuppression

UNKNOWN PHASE4

Phase I Study of Vaccination Schedule of Experimental HIV Vaccines

NCT00321061

HIV Infections

COMPLETED PHASE1

Safety of and Immune System Response to an HIV Vaccine (EP HIV-1090) in HIV Infected Patients

NCT00052182

HIV Infections

COMPLETED PHASE1

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

HIV Infections

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Rapid HIV Tested

Subjects have HIV testing by oral swab performed.

Group Type OTHER

HIV test by oral swab

Intervention Type OTHER

Eligible subjects underwent rapid HIV testing by oral swab.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

HIV test by oral swab

Eligible subjects underwent rapid HIV testing by oral swab.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

One of the following conditions:

* Sexually transmitted disease evaluation or prior history of sexually transmitted disease
* Pregnancy
* Clinical condition that suggests possible immunodeficiency
* History of illicit drug use
* History of chronic viral hepatitis
* Patients with unexplained pneumonia or recurrent pneumonia
* Male patients who have a history of sex with men
* Abdominal pain in a sexually active woman or urethritis in a man
* Trauma.
* Age 18 years old or older.